Drug company Merck & Co. is on trial for its Gardasil vaccine, used to treat human papillomavirus (HPV). Plaintiffs suing Merck claim that the vaccine caused serious health conditions, and that ...

Cervical cancer rates in the U.S. have dropped by more than half since the 1970s. Pap tests enable doctors to purge ...

9-valent human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52, and 58 vaccine; recombinant; aluminum adsorbed, susp for IM inj; preservative-free. Store refrigerated at 2°C to 8°C (36 ...

That's the question millions of parents face as television ads push for girls to receive Gardasil, a vaccine that prevents infection from four types of human papilloma virus (HPV)—the most ...

Firstly, let us look at Merck’s stock performance in recent years. MRK stock has seen strong gains of 55% from levels of $80 ...

Key TakeawaysMerck beat earnings and revenue estimates on strong sales of its Keytruda cancer medicine and Gardasil HPV ...

In this photo illustration, the Merck Sharp and Dohme logo is displayed on a ... [+] smartphone screen. (Photo Illustration ...

Gardasil is a vaccine, licensed for use in June 2006, by the FDA. It targets four strains of human papillomavirus (HPV) -- HPV-6, 11, 16, and 18. HPV-16 and HPV-18 account for about 70% of all ...

Todd McDermott and Nathalie Pozo go 'On the Record' to explore the local programs available in this unstable economy.

(Reuters) - Merck & Co on Thursday raised its annual profit and revenue forecast on the back of strong sales for its ...

GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.